Meperidine to control shivering associated with platelet transfusion reaction

  • Mark Friedlander
  • William H. Noble
Clinical Reports

Abstract

Shivering may be part of a febrile non-haemolytic reaction to blood product transfusion. Shivering can increase oxygen consumption up to 500 per cent which may be detrimental to patients with decreased myocardial reserve. A case is presented of a reaction to platelet transfusion characterized by shivering, tachycardia and hypertension in a patient with a recent myocardial infarction in whom the metabolic andhaemodynamic effects were considered to be potentially disastrous. Intravenous injection of meperidine was rapidly effective in treating these changes.

Key words

transfusion: reaction, platelet complications: myocardial infarction, shivering 

Résumé

Le frisson peut être le signe d’ une réaction non-hémolytique à la transfusion de dérivés sanguins. Il peut augmenter la consommation d’ oxygène par un facteur de cinq, exercice coûteux pour un coeur aux réserves limitées. Peu après un infarctus du myocarde, un de nos patients a reçu une transfusion de concentrés plaquettaires et il développa rapidement des tremblements avec tachycardie et hypertension dont les conséquences métaboliques et hémodynamiques nous faisaient craindre le pire. Pour traiter cette complication, l’injection intraveineuse de mépéridine savéra rapidement efficace.

References

  1. 1.
    Moir DD, Doyle PM. Halothane and postoperative shivering. Anesth Analg 1963; 42: 423–8.CrossRefGoogle Scholar
  2. 2.
    Brownridge P. Shivering related to epidural blockade with bupivacaine in labour, and the influence of epidural pethidine. Anaesth Intensive Care 1986; 14: 412–7.PubMedGoogle Scholar
  3. 3.
    Burks LC, Aisner J, Former CL, Wiernik PH. Meperidine for the treatment of shaking chills and fever. Arch Intern Med 1980; 140: 383–4.CrossRefGoogle Scholar
  4. 4.
    Widman FK (Ed.). Technical Manual, American Association of Blood Banks. 9th ed. 1985: 333.Google Scholar
  5. 5.
    Dawkins JM. Halothane. Lancet 1961; 2: 1259.Google Scholar
  6. 6.
    Bay J, Nunn JF, Prys-Roberts C. Factors influencing arterial PO2 during recovery from anaesthesia. Br J Anaesth 1968; 40: 398–407.PubMedCrossRefGoogle Scholar
  7. 7.
    Gonzales ER. Stopping post-op shivers eases rewarming. JAMA 1982; 248: 2802.CrossRefGoogle Scholar
  8. 8.
    Miller RD. Anesthesia. 2nd ed., New York: Churchill Livingstone Inc., 1986: 1358.Google Scholar
  9. 9.
    Herst R (Ed.). Clinical Guide to Transfusion. Canadian Red Cross Society Blood Services. 1987: 8–9.Google Scholar
  10. 10.
    Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 8th ed. Oxford: Blackwell Scientific Publications, 725–6.Google Scholar
  11. 11.
    Horvath SM, Spurr GB, Hutt BK, Hamilton LH. The metabolic cost of shivering. J Appl Physiol 1956; 8: 595–602.PubMedGoogle Scholar
  12. 12.
    Casey WF, Smith CE, Kan JM, O’Loughlin K, Weeks SK. Intravenous meperidine for control of shivering during Caesarean section under epidural anaesthesia. Can J Anaesth 1988; 35: 128–33.PubMedCrossRefGoogle Scholar
  13. 13.
    Cohen M. An investigation into shivering following anaesthesia: preliminary report. Proc Roy Soc Med 1967; 60: 18–9.Google Scholar
  14. 14.
    Pauca AL, Savage RT, Simpson S. Effect of pethidine, fentanyl and morphine on post-operative shivering in man. Acta Anaesthesiol Scand 1984; 28: 138–43.PubMedGoogle Scholar
  15. 15.
    Djerassi I, Jung Sun Kim. The Granulocyte: Function and Utilization. Alan R. Liss Inc. 1977, p. 312, New York.Google Scholar

Copyright information

© Canadian Anesthesiologists 1989

Authors and Affiliations

  • Mark Friedlander
    • 1
  • William H. Noble
    • 1
  1. 1.Department of Anaesthesia, Intensive Care Unit, St. Michael’s HospitalUniversity of TorontoToronto

Personalised recommendations